Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia-Reference-Cited by-同舟云学术

Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia

Published:2014-06-01 Issue:6 Volume:71 Page:637
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Umbricht Daniel¹,Alberati Daniela¹,Martin-Facklam Meret¹,Borroni Edilio¹,Youssef Eriene A.¹,Ostland Michael¹,Wallace Tanya L.²,Knoflach Frédéric¹,Dorflinger Ernest¹,Wettstein Joseph G.¹,Bausch Alexander³,Garibaldi George¹,Santarelli Luca¹

Affiliation:

1. F. Hoffmann-La Roche, Basel, Switzerland

2. SRI International, Menlo Park, California

3. F. Hoffmann-La Roche, Basel, Switzerland3now with Support Venture, Riehen, Switzerland

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preliminary screening of biomarkers and drug candidates in a mouse model of β-thalassemia based on quasi-targeted metabolomics;Frontiers in Physiology;2024-08-23

2. A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis;Cell Metabolism;2024-08

3. INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia;Schizophrenia Research;2024-08

4. Finding the right dose: NMDAR modulating treatments for cognitive and plasticity deficits in schizophrenia and the role of pharmacodynamic target engagement;Biological Psychiatry;2024-08

5. Dynamic role of GlyT1 as glycine sink or source: Pharmacological implications for the gain control of NMDA receptors;Neuroscience;2024-07